Page last updated: 2024-11-13
normosol r
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
normosol R: diluent for packed erythrocytes; Abbott Labs, contains NaCl, Na acetate, Na gluconate, KCl, MgCl (Am Drug Ind) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 56842124 |
MeSH ID | M0068440 |
Synonyms (13)
Synonym |
---|
isolyte s in plastic container |
physiosol ph 7.4 in plastic container |
normosol r |
normosol r-ph 7.4 |
physiosol in plastic container |
plasma-lyte 148 in water in plastic container |
68073-09-6 |
plasma-lyte a in plastic container |
physiolyte in plastic container |
normosol-r in plastic container |
isolyte s |
synovalyte in plastic container |
DTXSID80218287 |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
" A variety of adverse events (AEs) of varying severity have been noted during HPC infusions." | ( Infusion technique of hematopoietic progenitor cells and related adverse events (CME). Bryant, SC; Gastineau, DA; Greiner, CW; Hogan, WJ; Jacob, EK; Lingineni, RK; Mohr, A; Mulay, SB; Padley, D, 2014) | 0.4 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (11)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 54.93
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (54.93) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (9.09%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 2 (18.18%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (72.73%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |